Displaying 679 (all) recruiting clinical trials.
-
Multi-Center Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients with Moderate to Severe Respiratory Distress
The purpose of this study is to investigate whether hyperbaric oxygen therapy is an effective way to treat hypoxemia (low blood oxygen levels) in patients ...Phase N/A
Interventional
-
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults
This study seeks to meaningfully address the U.S. opioid epidemic by comparing the effectiveness of two medications used to treat opioid use disorder, extended-release ...Phase
Interventional
Accepts Healthy Volunteer
-
A Phase II Randomized Parallel-Group Double-Blind Double-Dummy Placebo-Controlled Multicenter Study To Evaluate The Efficacy Safety And Pharmacokinetics Of UTTR1147A Compared With Placebo And Compared With Vedolizumab In Patients
The purpose of this study is to compare the effects of UTTR1147A versus placebo (An inactive substance) and versus vedolizumab (ENTYVIO) on you and your ...Phase
Interventional
-
A Prospective Multi-Center Randomized Controlled Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients (PROACTIVE-HF Trial)
The main purpose of this research study is to reduce Heart Failure Hospitalizations. Endotronix, Inc. has begun a study of an investigational device (also known ... -
A randomized control trial to study the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program
The purpose of this study is to find out whether messages from providers (doctors) impact how people use diabetes prevention apps. This includes information on ...Phase N/A Accepts Healthy Volunteer
-
AALL1732 A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494 NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL Mixed Phenotype Acute Leukemia and Disseminated B-LLy
The purpose of the study is to determine the safety and efficacy of the investigational medicine Inotuzumab Ozogamicin for patients who have NCI high risk ...Phase
Interventional
-
A PHASE IB-II STUDY OF HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE BORTEZOMIB ABATACEPT AND SHORT-DURATION TACROLIMUS FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
The purpose of the study is to determine the safety and efficacy of cyclophosphamide, abatacept, and short-duration tacrolimus for GvHD prophylaxis following haploidentical hematopoietic stem ...Phase
Interventional
-
Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)
The purpose of this study is to compare two different minimally invasive procedures often used to treat the symptoms of benign prostatic hyperplasia (BPH): the ...Phase N/A Interventional
-
AHEP1531: Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
This trial is the first international cooperative liver tumors trial in which a consensus approach was established by investigators representing Children’s Oncology Group (COG ...Phase
Interventional
-
AALL1732: A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494 NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL Mixed Phenotype Acute Leukemia and Disseminated B-LLy
The primary aim of this study is to assess in a randomized fashion whether or not the incorporation of two cycles of inotuzumab ozogamicin (InO ...Phase
Interventional
